January 18, 2018 / 12:40 PM / Updated 32 minutes ago BRIEF-Strongbridge Biopharma Receives Notice Of Allowance From U.S. Patent And Trademark Office For New Patent Covering RECORLEV Reuters Staff 1 Min Read 
Jan 18 (Reuters) - Strongbridge Biopharma Plc: 
* STRONGBRIDGE BIOPHARMA RECEIVES NOTICE OF ALLOWANCE FROM U.S. PATENT AND TRADEMARK OFFICE FOR NEW PATENT COVERING RECORLEV™ (LEVOKETOCONAZOLE) FOR THE TREATMENT OF CUSHING’S SYNDROME 
* STRONGBRIDGE BIOPHARMA - ‍ TERM OF U.S. PATENT SCHEDULED TO ISSUE FROM APPLICATION WILL EXPIRE JAN 10, 2026, PLUS ANY TIME ALLOWED FOR TERM EXTENSION​ Source text for Eikon: Further company coverage: